ACCESSION: MSBNK-SMB_Measured-HSA015P0100017
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.03.05 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.05, Curated 2025.03.05)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 36
COMMENT: RAW_SPEC {'EL03_pos_2686': {'bp': 1098928.0, 'sum': 2366500.0}, 'EL24_pos_1964': {'bp': 365278.0, 'sum': 1274396.0}, 'EL11_pos_1933': {'bp': 378611.0, 'sum': 1341786.0}, 'EL23_pos_1939': {'bp': 519862.0, 'sum': 1607137.0}, 'EL22_pos_1877': {'bp': 870005.0, 'sum': 2157806.0}, 'EL04_pos_1913': {'bp': 483605.0, 'sum': 1362420.0}, 'EL05_pos_1887': {'bp': 490400.0, 'sum': 1502134.0}, 'EL07_pos_1871': {'bp': 481738.0, 'sum': 1376506.0}, 'EL09_pos_1901': {'bp': 521438.0, 'sum': 1445667.0}, 'EL17_pos_1895': {'bp': 597256.0, 'sum': 1605894.0}, 'EL23_pos_2002': {'bp': 457494.0, 'sum': 1476202.0}, 'EL08_pos_1982': {'bp': 380351.0, 'sum': 1282514.0}, 'EL20_pos_1900': {'bp': 629079.0, 'sum': 1613048.0}, 'EL14_pos_1983': {'bp': 557390.0, 'sum': 1529027.0}, 'EL14_pos_2043': {'bp': 481254.0, 'sum': 1519655.0}, 'EL20_pos_1957': {'bp': 464557.0, 'sum': 1479872.0}, 'EL17_pos_1951': {'bp': 447805.0, 'sum': 1463992.0}, 'EL20_pos_2013': {'bp': 429529.0, 'sum': 1502633.0}, 'EL13_pos_1922': {'bp': 423230.0, 'sum': 1392901.0}, 'EL10_pos_1946': {'bp': 375299.0, 'sum': 1315055.0}, 'EL14_pos_2433': {'bp': 301852.0, 'sum': 981841.0}, 'EL14_pos_1925': {'bp': 639420.0, 'sum': 1693722.0}, 'EL23_pos_1881': {'bp': 722702.0, 'sum': 1775073.0}, 'EL11_pos_1876': {'bp': 502501.0, 'sum': 1407607.0}, 'EL15_pos_1924': {'bp': 494743.0, 'sum': 1551303.0}, 'EL01_pos_1913': {'bp': 468151.0, 'sum': 1366167.0}, 'EL18_pos_1984': {'bp': 441371.0, 'sum': 1319841.0}, 'EL01_pos_1969': {'bp': 375859.0, 'sum': 1289569.0}, 'EL08_pos_2044': {'bp': 369701.0, 'sum': 1301740.0}, 'EL21_pos_1889': {'bp': 463558.0, 'sum': 1450796.0}, 'EL04_pos_1969': {'bp': 432958.0, 'sum': 1389447.0}, 'EL10_pos_1889': {'bp': 507500.0, 'sum': 1399791.0}, 'EL24_pos_1907': {'bp': 463564.0, 'sum': 1316220.0}, 'EL18_pos_2452': {'bp': 276542.0, 'sum': 994413.0}, 'EL18_pos_1923': {'bp': 543064.0, 'sum': 1501752.0}, 'EL08_pos_1923': {'bp': 542484.0, 'sum': 1512811.0}}
COMMENT: RETENTION_TIME_STDEV 0.274
COMMENT: PRECURSOR_M/Z_RAW 100.112625
COMMENT: PRECURSOR_M/Z_STDEV 0.000038
COMMENT: PRECURSOR_IN_MS1 mz 100.112111; int 34.388; delta(ppm) 0.970373
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.313; C6H13N; [M+H]+; delta(ppm) 0.312800
COMMENT: PROPOSED_MF MS-FINDER 3.451; C6H13N; [M+H]+; delta(ppm) 0.301123
COMMENT: PROPOSED_MF SIRIUS6_Sirius 9.752; C6H13N; [M+H]+; delta(ppm) 0.301123
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C6H13N; [M+H]+; delta(ppm) 0.301123
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.221; ONQBOTKLCMXPOF-UHFFFAOYSA-N; [M+H]+; CCN1CCCC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.016; PAMIQIKDUOTOBW-UHFFFAOYSA-N; [M+H]+; CN1CCCCC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.919; NNWUEBIEOFQMSS-UHFFFAOYNA-N; [M+H]+; CC1CCCCN1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.583; ZSIQJIWKELUFRJ-UHFFFAOYSA-N; [M+H]+; C1CCCNCC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.556; UZOFELREXGAFOI-UHFFFAOYSA-N; [M+H]+; N1CCC(C)CC1
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.961; PAFZNILMFXTMIY-UHFFFAOYSA-N; [M+H]+; Cyclohexylamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.659; PAMIQIKDUOTOBW-UHFFFAOYSA-N; [M+H]+; 1-methylpiperidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.586; AXTLFVLHXSDZOW-UHFFFAOYSA-N; [M+H]+; N-ethylmethacrylamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.503; KGNHJDRDIDXUHY-UHFFFAOYSA-N; [M+H]+; 4-methyl-3-penten-1-amine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.493; NNWUEBIEOFQMSS-UHFFFAOYNA-N; [M+H]+; 2-Methylpiperidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.482; ZSIQJIWKELUFRJ-UHFFFAOYSA-N; [M+H]+; azepane
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.447; ONQBOTKLCMXPOF-UHFFFAOYSA-N; [M+H]+; 1-ethylpyrrolidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.309; UZOFELREXGAFOI-UHFFFAOYSA-N; [M+H]+; 4-methylpiperidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; AXTLFVLHXSDZOW-UHFFFAOYSA-N; [M+H]+; N-ethylmethacrylamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; ONQBOTKLCMXPOF-UHFFFAOYSA-N; [M+H]+; 1-ethylpyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.799; NNWUEBIEOFQMSS-UHFFFAOYNA-N; [M+H]+; 2-Methylpiperidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.799; ZSIQJIWKELUFRJ-UHFFFAOYSA-N; [M+H]+; azepane
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.799; PAMIQIKDUOTOBW-UHFFFAOYSA-N; [M+H]+; 1-methylpiperidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.799; UZOFELREXGAFOI-UHFFFAOYSA-N; [M+H]+; 4-methylpiperidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.775; PAFZNILMFXTMIY-UHFFFAOYSA-N; [M+H]+; Cyclohexylamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.689; KGNHJDRDIDXUHY-UHFFFAOYSA-N; [M+H]+; 4-methyl-3-penten-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.413; PAFZNILMFXTMIY-UHFFFAOYSA-N; [M+H]+; cyclohexanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.127; ZSIQJIWKELUFRJ-UHFFFAOYSA-N; [M+H]+; azepane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.112; PAMIQIKDUOTOBW-UHFFFAOYSA-N; [M+H]+; 1-methylpiperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.527; NNWUEBIEOFQMSS-UHFFFAOYSA-N; [M+H]+; 2-methylpiperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.271; AXTLFVLHXSDZOW-UHFFFAOYSA-N; [M+H]+; N-ethyl-2-methylprop-2-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.256; UZOFELREXGAFOI-UHFFFAOYSA-N; [M+H]+; 4-methylpiperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.224; PBEJOEYAKXHDJT-UHFFFAOYSA-N; [M+H]+; hex-5-en-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.150; ONQBOTKLCMXPOF-UHFFFAOYSA-N; [M+H]+; 1-ethylpyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.121; FICBXRYQMBKLJJ-UHFFFAOYSA-N; [M+H]+; hex-5-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.115; HUEPADWXXGLLSW-UHFFFAOYSA-N; [M+H]+; N-prop-2-enylpropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.113; SQULHOYRZBAPJF-UHFFFAOYSA-N; [M+H]+; N-methylpent-4-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.113; OWUBKHTYXCOYMM-UHFFFAOYSA-N; [M+H]+; N-prop-2-enylpropan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.112; IGQKKHDDJXCEFL-UHFFFAOYSA-N; [M+H]+; 2-methylpent-4-en-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.111; DHOZGVQOZATZGP-UHFFFAOYSA-N; [M+H]+; 3-methylpent-4-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.070; JEGMWWXJUXDNJN-UHFFFAOYSA-N; [M+H]+; 3-methylpiperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.045; UHFLNWZBNRVHGM-UHFFFAOYSA-N; [M+H]+; N-(cyclopropylmethyl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.045; JPWYYRCELICUKE-UHFFFAOYSA-N; [M+H]+; N-ethylcyclobutanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.013; JFZLDRUSMYBXRI-UHFFFAOYSA-N; [M+H]+; 2-ethylpyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.005; DZFFQSFNUBWNSF-UHFFFAOYSA-N; [M+H]+; 3-ethylpyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.001; DAOWJXCNVJBLNI-UHFFFAOYSA-N; [M+H]+; N-propylcyclopropanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.000; OXXSMQHKMPTBAR-UHFFFAOYSA-N; [M+H]+; 1-cyclopropylpropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.000; RDOBCMAOFYDWKB-UHFFFAOYSA-N; [M+H]+; 3-ethylcyclobutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.000; DFEBPTMNVUHJRX-UHFFFAOYSA-N; [M+H]+; (1-ethylcyclopropyl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.999; OGZXOVGUHFDHOO-UHFFFAOYSA-N; [M+H]+; 2-propylazetidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.999; XGXNQIUNHHNDAQ-UHFFFAOYSA-N; [M+H]+; 1-ethylcyclobutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.999; ZADCUMFVTUWSAW-UHFFFAOYSA-N; [M+H]+; 1-propylcyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.999; JCGWCOCQLMXRKE-UHFFFAOYSA-N; [M+H]+; 3-ethyl-3-methylazetidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.999; PYIHBODUNRRGKT-UHFFFAOYSA-N; [M+H]+; 1-ethyl-N-methylcyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.999; XNPZNZSQFBQSTE-PHDIDXHHSA-N; [M+H]+; (1R,2R)-2-propylcyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.949; TYDMZADCGUWTCH-UHFFFAOYSA-N; [M+H]+; 2-methylcyclopentan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.948; LGSSDLSVHUCRFI-UHFFFAOYSA-N; [M+H]+; 3-methylcyclopentan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.895; GKZOJSZSGYEWSA-UHFFFAOYSA-N; [M+H]+; N,N,2-trimethylprop-2-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.894; ZEBFPAXSQXIPNF-UHFFFAOYSA-N; [M+H]+; 2,5-dimethylpyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.878; AZJUGPLDDAZZTB-NSCUHMNNSA-N; [M+H]+; (E)-hex-4-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.869; PHODFIDDEBEGCS-UHFFFAOYSA-N; [M+H]+; 2,2-dimethylpyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.866; XBQNZPDIRJPFAI-UHFFFAOYSA-N; [M+H]+; 3,3-dimethylpyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.860; KKTBUCVHSCATGB-UHFFFAOYSA-N; [M+H]+; N-methylcyclopentanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.858; DUOJVRWFIHNZTJ-UHFFFAOYSA-N; [M+H]+; 2,4-dimethylpyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.858; UBLYEVLMRSPMOG-UHFFFAOYSA-N; [M+H]+; cyclopentylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.857; ZKCLHJUZGZWTNA-UHFFFAOYSA-N; [M+H]+; 2,3-dimethylpyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.857; ATTVJWQVBUVDOP-UHFFFAOYSA-N; [M+H]+; 2,2,4-trimethylazetidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.856; MDVHHYGTBKHJAU-UHFFFAOYSA-N; [M+H]+; 2-propan-2-ylazetidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.839; TWASBYPJZBHZQJ-UHFFFAOYSA-N; [M+H]+; 1-methylcyclopentan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.837; OOXIEUXBOSSXJM-UHFFFAOYSA-N; [M+H]+; 2-cyclopropylpropan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.836; MGAPESYORZVKQD-UHFFFAOYSA-N; [M+H]+; 2-cyclobutylethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.836; RDEHRKLSYJBKDV-UHFFFAOYSA-N; [M+H]+; 3,4-dimethylpyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.836; XWGXFOVSOYMSGT-UHFFFAOYSA-N; [M+H]+; N-propan-2-ylcyclopropanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.836; DFDDLFCSYLTQBP-UHFFFAOYSA-N; [M+H]+; 1-cyclobutyl-N-methylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.836; FESRYVBBESMTNR-UHFFFAOYSA-N; [M+H]+; 3-cyclopropylpropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.834; GDGHPMLCHFTAIY-UHFFFAOYSA-N; [M+H]+; 1-cyclobutylethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.834; ULELCQYQCBHXFY-UHFFFAOYSA-N; [M+H]+; 2-cyclopropyl-N-methylethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.834; BRRVPUKFALTISS-UHFFFAOYSA-N; [M+H]+; N,1-dimethylcyclobutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.834; NZBCGJVYSMLKRN-UHFFFAOYSA-N; [M+H]+; (1-methylcyclobutyl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.834; BCEQMDPSJGINGM-UHFFFAOYSA-N; [M+H]+; 1-propan-2-ylcyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.834; MMWAHLXGFZBYQU-UHFFFAOYSA-N; [M+H]+; 2,2-dimethylcyclobutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.833; WFJUBRAHXQCZAM-UHFFFAOYSA-N; [M+H]+; 1-cyclopropylpropan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.833; VMVQWPJUETYXCM-UHFFFAOYSA-N; [M+H]+; N-methyl-1-(2-methylcyclopropyl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.833; GSVPWASAUVYUBM-UHFFFAOYSA-N; [M+H]+; (3-methylcyclobutyl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.833; DOAMTLHAIDSDBV-UHFFFAOYSA-N; [M+H]+; 1-(1-methylcyclopropyl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.833; CBWBPZZRBSZHEE-UHFFFAOYSA-N; [M+H]+; 1-cyclopropyl-N-methylethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.833; QTLHJKSNSNAIIC-UHFFFAOYSA-N; [M+H]+; 2-(1-methylcyclopropyl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.833; ZWMRWMKTTMIHRM-UHFFFAOYSA-N; [M+H]+; 1,3-dimethylcyclobutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.833; HNIFLEDIIDJDLD-UHFFFAOYSA-N; [M+H]+; 2,2,3-trimethylazetidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.833; IAYACHHAXQZZTQ-PHDIDXHHSA-N; [M+H]+; [(1S,2R)-2-methylcyclobutyl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.784; IHSJXWLJYTXOCL-UHFFFAOYSA-N; [M+H]+; N,N,2-trimethylprop-1-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.754; UCJOAMOXKLJGST-UHFFFAOYSA-N; [M+H]+; N-propan-2-ylpropan-2-imine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.754; VODADKFVZJNXGJ-UHFFFAOYSA-N; [M+H]+; 3-propan-2-ylazetidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.753; KGNHJDRDIDXUHY-UHFFFAOYSA-N; [M+H]+; 4-methylpent-3-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.753; ZZIYOZFERMXGHB-UHFFFAOYSA-N; [M+H]+; 3,3-dimethylcyclobutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.753; FPMPHZAUZKHZNK-UHFFFAOYSA-N; [M+H]+; (2,2-dimethylcyclopropyl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.752; JSLNMYHDORBKGU-UHFFFAOYSA-N; [M+H]+; 1,2,2-trimethylcyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.752; PAKOTDFUHRYXRU-NTSWFWBYSA-N; [M+H]+; (1R,2S)-2-propan-2-ylcyclopropan-1-amine
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C6H14N1; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 µm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 3.202
MS$FOCUSED_ION: PRECURSOR_M/Z 100.112106
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0udi-9700000000-8dd14dafd4fca0a1b619
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  53.0387654 11.6297 53.039463 1.1690 3.53 0.0065 30 f{C4H5}/3.56ppm,p-C2H9N1
  55.0180824 18.5646 55.018790 1.4359 4.90 0.4575 32 ?
  55.0545222 111.8313 55.055230 0.3633 39.78 0.0131 36 f{C4H7}/5.37ppm,p-C2H7N1
  56.0496628 10.9986 56.050375 1.1597 3.53 0.2343 30 f{C3H6N1}/3.34ppm,p-C3H8
  56.9649490 9.2807 56.965665 1.3166 5.44 -0.1343 34 ?
  57.0701635 19.9045 57.070880 1.2441 5.11 0.1572 34 f{C4H9}/5.03ppm,p-C2H5N1
  58.0653747 117.8582 58.066095 0.3100 6.71 -0.2368 36 f{C3H8N1}/4.29ppm,p-C3H6
  59.0493762 19.7897 59.050100 1.0500 7.51 0.0477 32 ?
  63.9424331 7.9011 63.943170 1.2668 2.36 0.2520 33 ?
  70.0652267 12.0206 70.065970 1.3273 5.63 0.1622 35 f{C4H8N1}/1.44ppm,p-C2H6
  71.0492668 29.7379 71.050010 0.9712 6.52 0.0456 36 ?
  71.0604154 6.3385 71.061159 1.3650 2.19 0.2320 29 ?
  72.0444571 10.6089 72.045200 1.0965 3.66 0.0133 31 ?
  72.0808921 68.0724 72.081635 0.5966 24.03 0.7608 36 f{C4H10N1}/1.61ppm,p-C2H4
  74.0965287 256.6608 74.097270 0.2699 10.01 -0.2196 36 f{C4H12N1}/1.39ppm,p-C2H2
  79.0543038 8.8481 79.055036 1.1764 2.43 -0.0861 30 f{C6H7}/0.98ppm,p-H7N1
  80.9451232 164.9938 80.945850 0.2841 42.09 0.4782 36 ?
  81.0699236 22.3559 81.070650 1.0238 5.75 0.0787 35 f{C6H9}/0.58ppm,p-H5N1
  81.9450365 10.6804 81.945760 1.3790 3.26 -0.1718 31 ?
  82.0287350 6.2562 82.029458 1.3166 2.06 0.0553 28 ?
  82.9419862 9.2006 82.942706 1.0972 2.73 0.1834 28 ?
  83.0127803 17.4591 83.013500 1.1926 4.95 0.0142 36 ?
  83.0492005 16.3943 83.049920 1.2643 4.50 0.1070 35 ?
  83.0855906 41.6000 83.086310 0.6138 9.83 -0.1248 36 f{C6H11}/0.77ppm,p-H3N1
  88.0042729 9.1897 88.004970 0.8636 3.69 0.0099 32 ?
  98.0600516 16.6333 98.060681 1.1422 4.16 -0.2601 29 ?
  98.0964660 6.4623 98.097095 1.4374 1.95 -0.1789 27 f{C6H12N1}/0.41ppm,p-H2
  98.9556484 34.6137 98.956270 0.9398 9.70 0.2389 36 ?
  98.9841986 450.9329 98.984820 0.2728 94.24 -0.1014 36 ?
  99.0440691 22.8297 99.044690 0.8683 5.42 0.1569 35 ?
  99.0553192 10.4972 99.055940 1.0701 2.83 0.2286 35 ?
  100.0392651 11.4617 100.039877 1.1396 3.68 -0.0616 30 ?
  100.0757331 62.9263 100.076345 0.4696 13.85 0.1256 36 ?
  100.1120635 57.7240 100.112675 0.8391 49.44 1.0000 36 f{C6H14N1}/-0.12ppm,p
  102.1277670 999.0000 102.128360 0.2448 0.00 -0.1905 36 ?
  116.9661432 130.8308 116.966610 0.4446 35.02 0.5444 36 ?
PK$NUM_PEAK: 36
PK$PEAK: m/z int. rel.int.
  53.038765 11.63 11
  55.018082 18.56 18
  55.054522 111.83 111
  56.049663 11.00 10
  56.964949 9.28 9
  57.070164 19.90 19
  58.065375 117.86 117
  59.049376 19.79 19
  63.942433 7.90 7
  70.065227 12.02 12
  71.049267 29.74 29
  71.060415 6.34 6
  72.044457 10.61 10
  72.080892 68.07 68
  74.096529 256.66 256
  79.054304 8.85 8
  80.945123 164.99 164
  81.069924 22.36 22
  81.945037 10.68 10
  82.028735 6.26 6
  82.941986 9.20 9
  83.012780 17.46 17
  83.049200 16.39 16
  83.085591 41.60 41
  88.004273 9.19 9
  98.060052 16.63 16
  98.096466 6.46 6
  98.955648 34.61 34
  98.984199 450.93 450
  99.044069 22.83 22
  99.055319 10.50 10
  100.039265 11.46 11
  100.075733 62.93 62
  100.112063 57.72 57
  102.127767 999.00 999
  116.966143 130.83 130
//
